Cellular targets of kinase inhibitors are identified by mass spectrometric analysis of binding to “kinobeads.”
References
Bantscheff, M. et al. Nat. Biotechnol. 25, 1035–1044 (2007).
Brehmer, D. et al. Cancer Res. 65, 379–382 (2005).
Godl, K. et al. Cancer Res. 65, 6919–6926 (2005).
Graves, P.R. et al. Mol. Pharmacol. 62, 1364–1372 (2002).
Haystead, C.M., Gregory, P., Sturgill, T.W. & Haystead, T.A. Eur. J. Biochem. 214, 459–467 (1993).
Ross, P.L. et al. Mol. Cell. Proteomics 3, 1154–1169 (2004).
Druker, B.J. et al. Nat. Med. 2, 561–566 (1996).
Shah, N.P. et al. Science 305, 399–401 (2004).
Golas, J.M. et al. Cancer Res. 63, 375–381 (2003).
Avivi-Green, C., Singal, M. & Vogel, W.F. Am. J. Respir. Crit. Care Med. 174, 420–427 (2006).
Daniels, C.E. et al. J. Clin. Invest. 114, 1308–1316 (2004).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
White, F. On the iTRAQ of kinase inhibitors. Nat Biotechnol 25, 994–996 (2007). https://doi.org/10.1038/nbt0907-994
Issue Date:
DOI: https://doi.org/10.1038/nbt0907-994
- Springer Nature America, Inc.